Literature DB >> 17934565

Prostate biopsy: current status and limitations.

Joseph C Presti1.   

Abstract

The technique of prostate biopsy has evolved over the past 10 years to improve our ability to detect prostate cancer. Extended biopsy schemes can be performed in the office under local anesthesia and are well tolerated. In addition to detection, the role of extended biopsy schemes in refining tumor grading and risk assessment has become better defined. This review discusses the evolution of prostate biopsy techniques from the sextant scheme to the extended scheme and demonstrates the latter's utility in clinical decision making.

Entities:  

Keywords:  Prostate biopsy; Prostate cancer

Year:  2007        PMID: 17934565      PMCID: PMC2002498     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  26 in total

1.  Outcome of sextant biopsy according to gland volume.

Authors:  P I Karakiewicz; M Bazinet; A G Aprikian; C Trudel; S Aronson; M Nachabé; F Péloquint; J Dessureault; M S Goyal; L R Bégin; M M Elhilali
Journal:  Urology       Date:  1997-01       Impact factor: 2.649

2.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

Review 3.  Making the most out of six systematic sextant biopsies.

Authors:  T A Stamey
Journal:  Urology       Date:  1995-01       Impact factor: 2.649

4.  Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.

Authors:  Stephen J Freedland; Christopher J Kane; Christopher L Amling; William J Aronson; Martha K Terris; Joseph C Presti
Journal:  Urology       Date:  2007-03       Impact factor: 2.649

5.  Saturation technique does not improve cancer detection as an initial prostate biopsy strategy.

Authors:  J Stephen Jones; Amit Patel; Lynn Schoenfield; John C Rabets; Craig D Zippe; Cristina Magi-Galluzzi
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

6.  Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.

Authors:  René Raaijmakers; Mark F Wildhagen; Kazuto Ito; Alvaro Pàez; Stijn H de Vries; Monique J Roobol; Fritz H Schröder
Journal:  Urology       Date:  2004-02       Impact factor: 2.649

7.  Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies.

Authors:  Y Mark Hong; Frank C Lai; Chris H Chon; John E McNeal; Joseph C Presti
Journal:  Urol Oncol       Date:  2004 Jan-Feb       Impact factor: 3.498

8.  uPM3, a new molecular urine test for the detection of prostate cancer.

Authors:  Yves Fradet; Fred Saad; Armen Aprikian; Jean Dessureault; Mostafa Elhilali; Claude Trudel; Benoît Mâsse; Lyson Piché; Camille Chypre
Journal:  Urology       Date:  2004-08       Impact factor: 2.649

9.  Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer.

Authors:  W H Cooner; B R Mosley; C L Rutherford; J H Beard; H S Pond; R B Bass; W J Terry
Journal:  J Urol       Date:  1988-04       Impact factor: 7.450

10.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

Authors:  K K Hodge; J E McNeal; M K Terris; T A Stamey
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450

View more
  16 in total

1.  Transrectal Ultrasound-guided Versus Transperineal Mapping Prostate Biopsy: Complication Comparison.

Authors:  Vassilios M Skouteris; E David Crawford; Vladimir Mouraviev; Paul Arangua; Marios Panagiotis Metsinis; Michael Skouteris; George Zacharopoulos; Nelson N Stone
Journal:  Rev Urol       Date:  2018

2.  The role of combined measurement of tissue mRNA levels of AMACR and survivin in the diagnosis and risk stratification of patients with suspected prostate cancer.

Authors:  May Al-Maghrebi; Elijah O Kehinde; Jehoram T Anim; Mehraj Sheikh
Journal:  Int Urol Nephrol       Date:  2012-06-21       Impact factor: 2.370

Review 3.  Prostate zones and cancer: lost in transition?

Authors:  Amin Ali; Alexander Du Feu; Pedro Oliveira; Ananya Choudhury; Robert G Bristow; Esther Baena
Journal:  Nat Rev Urol       Date:  2021-10-19       Impact factor: 14.432

4.  MRI-targeted biopsy cores from prostate index lesions: assessment and prediction of the number needed.

Authors:  Nick Lasse Beetz; Franziska Dräger; Charlie Alexander Hamm; Seyd Shnayien; Madhuri Monique Rudolph; Konrad Froböse; Sefer Elezkurtaj; Matthias Haas; Patrick Asbach; Bernd Hamm; Samy Mahjoub; Frank Konietschke; Maximilian Wechsung; Felix Balzer; Hannes Cash; Sebastian Hofbauer; Tobias Penzkofer
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-10-08       Impact factor: 5.455

5.  Evaluation of Frequency Domain Analysis of a Multiwavelength Photoacoustic Signal for Differentiating Malignant From Benign and Normal Prostates: Ex Vivo Study With Human Prostates.

Authors:  Saugata Sinha; Navalgund A Rao; Bhargava K Chinni; Vikram S Dogra
Journal:  J Ultrasound Med       Date:  2016-08-29       Impact factor: 2.153

Review 6.  Pathologic basis of focal therapy for early-stage prostate cancer.

Authors:  Vladimir Mouraviev; Janice M Mayes; Thomas J Polascik
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

7.  Preliminary study on ultrasound-guided prostate biopsy specimen scores.

Authors:  Cheng Li; Weiwei Zhan; Minguang Zhang; Fangxiu Luo; Yan Wang; Bin Zheng
Journal:  Exp Ther Med       Date:  2017-07-18       Impact factor: 2.447

8.  Targeted biopsy based on ADC map in the detection and localization of prostate cancer: a feasibility study.

Authors:  Yuji Watanabe; Masako Nagayama; Tohru Araki; Akito Terai; Akira Okumura; Yoshiki Amoh; Takayoshi Ishimori; Satoru Nakashita; Yoshihiro Dodo
Journal:  J Magn Reson Imaging       Date:  2012-11-16       Impact factor: 4.813

9.  Prostate Biopsy in the Left Lateral Decubitus Position is Less Painful than Prostate Biopsy in the Lithotomy Position: A Randomized Controlled Trial.

Authors:  Branimir Lodeta; Maja Lodeta
Journal:  Korean J Urol       Date:  2012-02-20

10.  What is the consistency between the results of needle biopsy and prostatectomy specimen pathology results? A pilot study

Authors:  Ömer Ozan Yıldızlı; İbrahim Üntan; Deniz Demirci
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.